MARK J CULANAG

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LAS VEGAS, NV NPI 1306489331

General Payments — all program years on this page

$995.31

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 55
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $326.66 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $326.6616

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $76.693
Lilly USA, LLC $56.404
Amgen Inc. $51.542
PFIZER INC. $42.202
Astellas Pharma US Inc $40.472
Daiichi Sankyo Inc. $21.111
Phathom Pharmaceuticals, Inc. $20.791
Acerta Pharma LLC $17.461

By program year

Program yearAmountRecords
2021 $79.926
2022 $441.5826
2023 $147.157
2024 $326.6616

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1089412126 Daiichi Sankyo Inc. $21.11 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100300443 Novo Nordisk Inc $22.15 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100356878 Novo Nordisk Inc $22.91 09/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100555289 Novo Nordisk Inc $31.63 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105486551 AstraZeneca Pharmaceuticals LP $17.46 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117231651 Amgen Inc. $22.89 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117231653 Amgen Inc. $28.65 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131411809 PFIZER INC. $24.37 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1131794013 PFIZER INC. $17.83 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135777122 Lilly USA, LLC $14.25 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135807525 Lilly USA, LLC $13.80 07/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135807527 Lilly USA, LLC $14.13 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135809037 Lilly USA, LLC $14.22 08/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139486614 Astellas Pharma US Inc $13.14 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139512915 Astellas Pharma US Inc $27.33 05/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151158432 Phathom Pharmaceuticals, Inc. $20.79 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.